Back to Search Start Over

Identification ofHaemophilus haemolyticusin clinical samples and characterization of their mechanisms of antimicrobial resistance

Authors :
Fe Tubau
Carmen Ardanuy
Carmen Puig
Josefina Liñares
Josefina Ayats
Arnau Domenech
José Manuel Tirado-Vélez
Adela G. de la Campa
Dolors Garcia-Somoza
Sara Martí
Laura Calatayud
Source :
Journal of Antimicrobial Chemotherapy. 71:80-84
Publication Year :
2015
Publisher :
Oxford University Press (OUP), 2015.

Abstract

Objectives The objectives of this study were to establish the frequency of Haemophilus haemolyticus in clinical samples, to determine the antimicrobial resistance rate and to identify the mechanisms of resistance to β-lactams and quinolones. Methods An updated database was used to differentiate between MALDI-TOF MS results for Haemophilus influenzae and H. haemolyticus. Antimicrobial susceptibility was studied by microdilution, following EUCAST criteria. The β-lactamase types were identified by PCR analysis of isolates that tested positive for nitrocefin hydrolysis. Mutations in the ftsI gene were identified in isolates with ampicillin MICs ≥0.25 mg/L. Mutations in the quinolone resistance-determining region (QRDR) were identified in isolates with ciprofloxacin MICs ≥0.5 mg/L. Results Overall, we identified 69 H. haemolyticus isolates from 1706 clinical isolates of Haemophilus spp. from respiratory, genital, invasive, and other infection sources. The frequency of H. haemolyticus was low in respiratory samples compared with that of H. influenzae, but in genital-related samples, the frequency was similar to that of H. influenzae. We found low antimicrobial resistance rates among H. haemolyticus isolates, with 8.7% for ampicillin, 8.7% for co-trimoxazole, 7.2% for tetracycline and 4.3% for ciprofloxacin. Mutations in the ftsI gene classified the isolates into four groups, including the newly described Group Hhae IV, which presents mutations in the ftsI gene not identified in H. influenzae and H. haemolyticus type strains. Three ciprofloxacin-resistant H. haemolyticus isolates with mutations affecting GyrA and ParC were identified. Conclusions The frequency of H. haemolyticus was low, especially in respiratory samples, where H. influenzae is the main pathogen of this genus. Although antimicrobial resistance rates were low, three ciprofloxacin-resistant H. haemolyticus clinical isolates have been identified for the first time.

Details

ISSN :
14602091 and 03057453
Volume :
71
Database :
OpenAIRE
Journal :
Journal of Antimicrobial Chemotherapy
Accession number :
edsair.doi.dedup.....eb075985215dc3ab779eac9cb78a6b9e
Full Text :
https://doi.org/10.1093/jac/dkv307